Find the right fit for you - faster
Get tailored insights about working at Spyre Therapeutics in one quick step.
Spyre Therapeutics Snapshot
At Spyre, our team has deep experience developing and commercializing treatments across a broad range of diseases, and is committed to improving the lives of patients.
Spyre is developing next-generation antibodies that are engineered for prolonged activity in the body and formulated for delivery as monotherapies or combination therapies. Our innovative approach enables the exploration of treatment options with the potential to deliver uncompromising efficacy and convenience
Spyre is developing next-generation antibodies that are engineered for prolonged activity in the body and formulated for delivery as monotherapies or combination therapies. Our innovative approach enables the exploration of treatment options with the potential to deliver uncompromising efficacy and convenience
Spyre Therapeutics is a clinical-stage biotechnology company committed to developing next-generation therapies that elevate the standard in immunology by delivering more complete disease control, greater durability, and a simpler treatment experience for patients. Spyre's pipeline includes investigational extended half-life antibodies targeting α4β7, TL1A, and IL-23.
